Antimetabolites: all 7,305 studies that test it
Page 40 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Locally Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT03559348Phase 2
- A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic LymphomaStatus unknownNCT03558412Phase 4
- A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351CompletedNCT03555955Phase 1
- Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell LymphomaStatus unknownNCT03553537Phase 3
- Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadActive, not recruitingNCT03547973Phase 2
- Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line TreatmentStatus unknownNCT03536780Phase 2
- Safety and Efficacy Evaluation of Decitabine With R-GDPStatus unknownNCT03535753Phase 1
- T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic AnemiaActive, not recruitingNCT03531736Phase 1
- A Study to Evaluate MEDI5752 in Subjects With Advanced Solid TumorsActive, not recruitingNCT03530397Phase 1
- Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCTStatus unknownNCT03530085Phase 2/3
- Scheduling Nab-paclitaxel With GemcitabineCompletedNCT03529175Phase 2
- NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue SarcomaTerminatedNCT03524898Phase 1/2
- Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLLCompletedNCT03524235Phase 1
- Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic CancerActive, not recruitingNCT03523312Phase 2
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute LeukemiaTerminatedNCT03519984Phase 1
- Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder CancerTerminatedNCT03518320Phase 1
- Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast CancerCompletedNCT03518242Phase 1
- TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRCCompletedNCT03517618Phase 2
- CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic CancerCompletedNCT03517176Phase 1
- Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMITerminatedNCT03516903Phase 2/3
- Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML PatientsStatus unknownNCT03515018Phase 3
- Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid LeukemiaActive, not recruitingNCT03513484Phase 1
- Cycloserine rTMS Plasticity Augmentation in DepressionCompletedNCT03511599Phase 1
- Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid TumorsCompletedNCT03509012Phase 1
- Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid TumorsCompletedNCT03507491Phase 1
- Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid TumorsCompletedNCT03507244Phase 1/2
- Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of ArthritisStatus unknownNCT03506919Phase 1/2
- Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLMTerminatedNCT03500874Phase 3
- Study in Patients With Tumours Requiring Arginine to Assess ADI-PEG 20 With Atezolizumab, Pemetrexed and CarboplatinWithdrawnNCT03498222Phase 1
- Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With GemcitabineCompletedNCT03496779Phase 2
- Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous SystemCompletedNCT03495960Phase 2
- Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic SyndromeSuspendedNCT03494569Phase 1
- Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486CompletedNCT03493646Phase 2
- A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLMCompletedNCT03493061Phase 2
- Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.Status unknownNCT03491696Phase 4
- Epacadostat, Cladribine and Cytarabine (ECC) in AMLWithdrawnNCT03491579Phase 1
- First-line Therapy in Metastatic PDACStatus unknownNCT03487016Phase 2
- Avelumab/Gemcitabine in Sarcomatoid RCCTerminatedNCT03483883Phase 1
- Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTCCompletedNCT03478488Phase 3
- A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant TherapyCompletedNCT03473639Phase 1
- CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALLActive, not recruitingNCT03467256Phase 1/2
- Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.Status unknownNCT03467178Phase 2
- Association of Capecitabine Pharmacokinetics and Toxicity With AgingStatus unknownNCT03465202Phase 4
- mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First LineCompletedNCT03464968Phase 2
- Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)Status unknownNCT03463733Phase 1
- Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.TerminatedNCT03460678Phase 4
- Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDSCompletedNCT03459859Phase 1
- S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLCStatus unknownNCT03457337Phase 2
- Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell LymphomaCompletedNCT03450343Phase 1
- Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With MyelomaTerminatedNCT03448978Phase 1
- Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)Active, not recruitingNCT03448835Phase 2
- Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young AdultsCompletedNCT03445858Early Phase 1
- Epacadostat, Idarubicin and Cytarabine (EIC) in AMLWithdrawnNCT03444649Phase 1
- SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic CancerCompletedNCT03443492Phase 2
- Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT03441048Phase 1
- A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract CancerActive, not recruitingNCT03440450Phase 1
- Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction TherapyCompletedNCT03435848Phase 2
- A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed ConditionStatus unknownNCT03435666Phase 1
- A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic CancerStatus unknownNCT03435289Phase 1
- AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin LymphomaActive, not recruitingNCT03434769Phase 1
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- Cycloserine rTMS Plasticity AugmentationCompletedNCT03432689Phase 1
- Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer.CompletedNCT03428529Phase 2/3
- Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric CancerStatus unknownNCT03427684Phase 1/2
- Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal CarcinomaCompletedNCT03427359Phase 2
- The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage TherapyStatus unknownNCT03423849Phase 2/3
- A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AMLStatus unknownNCT03417427Phase 2
- Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic CancerCompletedNCT03415802Phase 2
- Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic CancerCompletedNCT03412799Phase 1
- Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic OvarianStatus unknownNCT03412526Phase 2
- RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCTStatus unknownNCT03412266Phase 2
- Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe PsoriasisStatus unknownNCT03408756Phase 4
- Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT03406299Phase 2
- A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical CystectomyCompletedNCT03404791Phase 1
- Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic SyndromeTerminatedNCT03404193Phase 2
- Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 StageStatus unknownNCT03403829Phase 3
- Carbon Ion Radiation Therapy for Locally Advanced Pancreatic CancerCompletedNCT03403049Phase 1
- The EPIC Trial The Elderly Patient Individualized Chemotherapy TrialStatus unknownNCT03402048Phase 3
- The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic CancerStatus unknownNCT03401827Phase 4
- XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)CompletedNCT03399110Phase 3
- Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal CancerStatus unknownNCT03397199Phase 2
- TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic AcidCompletedNCT03397173Phase 2
- CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic SyndromeCompletedNCT03393611Phase 1
- Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer PatientsWithdrawnNCT03392571Phase 2
- Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical ResectionStatus unknownNCT03392103Phase 2
- CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomasTerminatedNCT03387592Phase 2
- Allopurinol and Endothelial Function in Diabetic CAD PatientsStatus unknownNCT03385135Not applicable
- CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AMLStatus unknownNCT03384225Phase 3
- CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AMLStatus unknownNCT03384212Phase 3
- Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 MutationsStatus unknownNCT03381781Phase 2
- Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal CancerStatus unknownNCT03381352Phase 2
- Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML PatientsTerminatedNCT03381118Phase 2
- A Phase III, Randomized, Multi-center Study to Determine the Efficacy of the Intercalating Combination Treatment of Chemotherapy and Gefitinib or Chemotherapy as Adjuvant Treatment in NSCLC With Common EGFR Mutations.Status unknownNCT03381066Phase 3
- Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple MyelomaStatus unknownNCT03380039Not applicable
- Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast CancerCompletedNCT03377387Phase 1/2
- To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With CorticosteroidsCompletedNCT03371667Phase 3
- Add-on Methotrexate for the Treatment of SchizophreniaStatus unknownNCT03369795Phase 2
- TAS102 in Combination With NAL-IRI in Advanced GI CancersActive, not recruitingNCT03368963Phase 1/2
- Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESCStatus unknownNCT03366883Phase 3
- Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPCStatus unknownNCT03366415Phase 3